Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Peters

Showing results (31-40 of 380) with videos related to

Pageof 38
Sort By:
Nucleic Acids Symposium Series (2004)|September 9, 2008
Thymidine phoshorylase as a target for antiangiogenesis treatmentG J Peters, I V Bijnsdorp, M Fukushima
Biochimica Et Biophysica Acta|January 4, 1983
Metabolism of purine nucleosides in human and ovine lymphocytes and rat thymocytes and their influence on mitogenic stimulationG J Peters, A Oosterhof, J H Veerkamp
The International Journal of Biochemistry|January 1, 1981
Adenosine and deoxyadenosine metabolism in mammalian lymphocytesG J Peters, A Oosterhof, J H Veerkamp
Pharmacy World & Science : PWS|April 15, 1994
New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinaseV W Ruiz van Haperen, G J Peters
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2006
Purine and pyrimidine metabolism: a firm basis for a transformed societyG J Peters, E A Carrey, I Sebesta
The International Journal of Biochemistry|January 1, 1979
Pyrimidine metabolism in lymphocytes and erythrocytes of man, horse and cattleW J Tax, G J Peters, J H Veerkamp
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 1988
A sensitive non-radioactive assay for pyrimidine nucleoside phosphorylase using reversed-phase high performance liquid chromatographyE J Laurensse, H M Pinedo, G J Peters
Cancer Surveys|January 1, 1993
Clinical pharmacokinetics of anti-metabolitesG J Peters, J H Schornagel, G A Milano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitorG J Peters, C J van Groeningen, G Giaccone
European Journal of Pharmacology|April 3, 2001
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cellsA M Bergman, H M Pinedo, G J Peters
Pageof 38

Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Nucleic Acids Symposium Series (2004)|September 9, 2008
Thymidine phoshorylase as a target for antiangiogenesis treatmentG J Peters, I V Bijnsdorp, M Fukushima
Biochimica Et Biophysica Acta|January 4, 1983
Metabolism of purine nucleosides in human and ovine lymphocytes and rat thymocytes and their influence on mitogenic stimulationG J Peters, A Oosterhof, J H Veerkamp
The International Journal of Biochemistry|January 1, 1981
Adenosine and deoxyadenosine metabolism in mammalian lymphocytesG J Peters, A Oosterhof, J H Veerkamp
Pharmacy World & Science : PWS|April 15, 1994
New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinaseV W Ruiz van Haperen, G J Peters
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2006
Purine and pyrimidine metabolism: a firm basis for a transformed societyG J Peters, E A Carrey, I Sebesta
The International Journal of Biochemistry|January 1, 1979
Pyrimidine metabolism in lymphocytes and erythrocytes of man, horse and cattleW J Tax, G J Peters, J H Veerkamp
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 1, 1988
A sensitive non-radioactive assay for pyrimidine nucleoside phosphorylase using reversed-phase high performance liquid chromatographyE J Laurensse, H M Pinedo, G J Peters
Cancer Surveys|January 1, 1993
Clinical pharmacokinetics of anti-metabolitesG J Peters, J H Schornagel, G A Milano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitorG J Peters, C J van Groeningen, G Giaccone
European Journal of Pharmacology|April 3, 2001
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cellsA M Bergman, H M Pinedo, G J Peters
Pageof 38